(Q33278013)

25 July 2017

Enhanced deacetylation of p53 by the anti-apoptotic protein HSCO in association with histone deacetylase 1. (English)

1 reference

25 July 2017

0 references

Hisako Higashitsuji

1

1 reference

25 July 2017

Hiroaki Higashitsuji

2

1 reference

25 July 2017

Tomoko Masuda

3

1 reference

25 July 2017

Yu Liu

4

1 reference

25 July 2017

Katsuhiko Itoh

5

1 reference

25 July 2017

Jun Fujita

6

1 reference

25 July 2017

language of work or name

English

0 references

publication date

12 March 2007

1 reference

Journal of Biological Chemistry

25 July 2017

1 reference

25 July 2017

282

1 reference

25 July 2017

18

1 reference

25 July 2017

13716-13725

1 reference

25 July 2017

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

Post-translational modification of p53 in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

Live or let die: the cell's response to p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

The p53-Mdm2 module and the ubiquitin system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

p53 ubiquitination: Mdm2 and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

Regulation of p53 responses by post-translational modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

DNA damage activates p53 through a phosphorylation-acetylation cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

Histone deacetylases (HDACs): characterization of the classical HDAC family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

Acetylation and deacetylation of non-histone proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

Histone deacetylases specifically down-regulate p53-dependent gene activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

Deacetylation of p53 modulates its effect on cell growth and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

Hepatocellular carcinoma: the need for progress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

Systemic treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

Apg-2 has a chaperone-like activity similar to Hsp110 and is overexpressed in hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

Tumor necrosis factor: an apoptosis JuNKie?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

Impairment of p53 acetylation, stability and function by an oncogenic transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

Overexpression of histone deacetylase 1 confers resistance to sodium butyrate-mediated apoptosis in melanoma cells through a p53-mediated pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

Acetylation of the p53 DNA-binding domain regulates apoptosis induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

The C-terminal lysines fine-tune P53 stress responses in a mouse model but are not required for stability control or transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

Charge modification at multiple C-terminal lysine residues regulates p53 oligomerization and its nucleus-cytoplasm trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

Transcription factor NF-kappaB differentially regulates death receptor 5 expression involving histone deacetylase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

Genetic changes and histopathological grades in human hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609751200

21 January 2018

Identifiers

DOI

10.1074/JBC.M609751200

1 reference

25 July 2017

1 reference